3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
12
Pain, Postoperative
11
Pain
11
Breast Neoplasms
9
Agnosia
9
Depression
8
Head and Neck Neoplasms
6
Chronic Pain
4
Anxiety Disorders
4
Pancreatic Neoplasms
3
Pain, Intractable
3
Colorectal Neoplasms
3
Acute Pain
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mucositis
2
Gastrointestinal Neoplasms
2
Cancer Pain
2
Stomatitis
1
Spinal Stenosis
1
Rectal Neoplasms
1
Postoperative Analgesia
1
Peripheral Nervous System Diseases
1
Pelvic Neoplasms
1
Pain, Procedural
1
Otolaryngeal Cancer
1
Neurotoxicity Syndromes
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Laparoscopic Colorectal Resection Due to Cancer
1
Interventions
Morphine
1
Ketamine
1
Chitosan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cancer: Breakthrough Pain
×
Ketamine
×
Clear all
NCT02591017
2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3
Terminated
11 enrolled